________________________________________________________________________________________________________________________________

(C) MediGene 2009 - ManagementMediGene Set to Implement Strategic Turnaround

September 2009. For many months the TecDax-company has been announcing to re-focus its business. Shareholders at the Annual Meeting learned about the more concrete plans to generate sustainable profitability with Frank Mathias coming from Amgen Germany.

 

 

 

If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)

Article free of advertisement - 1 page
- Includes financial Comparison of TecDax Performance September 2009

Full Company License enquire here

Back to section

Related Editorial Articles

Eurofins helps Pasteur de Lille out of the doldrums
Prospects of IPL’s analytical services business

Systems Biology Applied
Rudi Balling, Director of the Luxembourg Centre for Systems Biomedicine, on the need of systems theory thinking in using technologies and pitfalls of some concepts

Bayer: No Mercy with Violators of Corporate Compliance
Rüdiger Scheitza, Member of the Board Bayer CropScience, and Labour Director (until June 2013) on dealing with corrupt practices

Stem Cells and Vaccines
Majid Mehtali, CSO Vivalis on the Way Forward to BioManufacturing

Custom Sequencing Markets
Worldwide evolution of the market and upcoming business opportunities